Professor Dan Siskind
Professor

Dan Siskind

Email: 
Phone: 
+61 7 3176 2860

Background

Prof Siskind trained as a psychiatrist in Australia and the United States. He graduated from medicine at the University of Queensland in 1998. After working with Doctors Without Borders in Chechnya in 2000, he became interested in psychiatry. He moved to Boston in 2002, where he did his psychiatry residency at Boston University and a Master of Public Health at Harvard University. He returned to Brisbane in June 2008 as a clinical academic psychiatrist at the Metro South Addiction and Mental Health Service. He completed his Ph.D in Feb 2014. His research interests include clozapine and treatment refractory schizophrenia, the physical health of people with severe and persistent mental illness, supported accommodation, assertive community treatment and mental health services research. He has been awarded an NHMRC Investigator Grant as an Emerging Leadership Fellow (2021-2025) and held an NHMRC Early Career Fellowship (2016-2019). He has a current CIA MRFF RCRDUN grant looking at treatments to reduce cardiometabolic morbidity among people with schizophrenia. He has over 200 peer reviewed publications, including first author in the highly ranked Lancet, World Psychiatry, Lancet Psychiatry, BJPsych, ANZJP, & Schizophrenia Bulletin. He is a named investigator on over $40 million in competitive research grants, with over $6 million as CIA.

Availability

Professor Dan Siskind is:
Available for supervision
Media expert

Fields of research

Health Sciences Psychology

Research interests

  • Schizophrenia

  • Physical Health Comorbidity

Search Professor Dan Siskind’s works on UQ eSpace

376 works between 2007 and 2025
All (376) Journal Article (286) Book Chapter (1) Conference Publication (83) Other Outputs (6)

21 - 40 of 376 works

2024

Journal Article

Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophrenia

Siskind, Dan, Bull, Claudia, Suetani, Shuichi, Warren, Nicola, Suraev, Anastasia, McGregor, Iain, Kisely, Steve, De Monte, Veronica, Trott, Mike, Shine, Manju, Moudgil, Vikas, Robinson, Gail, Parker, Stephen, Krishnaiah, Ravikumar, Stedman, Terry, Drummond, Allan, Medland, Sarah, Iyer, Ravi and Baker, Andrea (2024). Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophrenia. BJPsych Open, 10 (5) e156, 1-7. doi: 10.1192/bjo.2024.748

Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophrenia

2024

Journal Article

The role of human involvement and support in digital mental health interventions for people with schizophrenia spectrum disorders: a critical review

Arnautovska, Urska, Milton, Alyssa, Trott, Mike, Soole, Rebecca and Siskind, Dan (2024). The role of human involvement and support in digital mental health interventions for people with schizophrenia spectrum disorders: a critical review. Current Opinion in Psychiatry, 37 (5), 356-362. doi: 10.1097/yco.0000000000000957

The role of human involvement and support in digital mental health interventions for people with schizophrenia spectrum disorders: a critical review

2024

Journal Article

Hospital admissions and community health service contacts for mental illness following self-reported child maltreatment: results from the Childhood Adversity and Lifetime Morbidity (CALM) study

Trott, Mike, Bull, Claudia, Najman, Jake Moses, Arnautovska, Urska, Siskind, Dan, Warren, Nicola and Kisely, Steve (2024). Hospital admissions and community health service contacts for mental illness following self-reported child maltreatment: results from the Childhood Adversity and Lifetime Morbidity (CALM) study. Child Abuse and Neglect, 154 106912, 106912. doi: 10.1016/j.chiabu.2024.106912

Hospital admissions and community health service contacts for mental illness following self-reported child maltreatment: results from the Childhood Adversity and Lifetime Morbidity (CALM) study

2024

Journal Article

Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders – An individual patient data meta-analysis

Campana, Mattia, Yakimov, Vladislav, Moussiopoulou, Joanna, Maurus, Isabel, Löhrs, Lisa, Raabe, Florian, Jäger, Iris, Mortazavi, Matin, Benros, Michael E., Jeppesen, Rose, Meyer zu Hörste, Gerd, Heming, Michael, Giné-Servén, Eloi, Labad, Javier, Boix, Ester, Lennox, Belinda, Yeeles, Ksenija, Steiner, Johann, Meyer-Lotz, Gabriela, Dobrowolny, Henrik, Malchow, Berend, Hansen, Niels, Falkai, Peter, Siafis, Spyridon, Leucht, Stefan, Halstead, Sean, Warren, Nicola, Siskind, Dan, Strube, Wolfgang ... Wagner, Elias (2024). Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders – An individual patient data meta-analysis. Brain, Behavior, and Immunity, 119, 353-362. doi: 10.1016/j.bbi.2024.04.011

Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders – An individual patient data meta-analysis

2024

Journal Article

Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysis

Rogdaki, Maria, McCutcheon, Robert A., D'Ambrosio, Enrico, Mancini, Valentina, Watson, Cameron J., Fanshawe, Jack B., Carr, Richard, Telesia, Laurence, Martini, Maria Giulia, Philip, Aaron, Gilbert, Barnabas J., Salazar-de-Pablo, Gonzalo, Kyriakopoulos, Marinos, Siskind, Dan, Correll, Christoph U., Cipriani, Andrea, Efthimiou, Orestis, Howes, Oliver D. and Pillinger, Toby (2024). Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysis. The Lancet Child and Adolescent Health, 8 (7), 510-521. doi: 10.1016/S2352-4642(24)00098-1

Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysis

2024

Journal Article

Response rates to sequential trials of antipsychotic medications according to algorithms or treatment guidelines in psychotic disorders. A systematic review and meta-analysis

O'Donoghue, Brian, Piacenza, Francesco, Plapp, Helena, Siskind, Dan and Lyne, John (2024). Response rates to sequential trials of antipsychotic medications according to algorithms or treatment guidelines in psychotic disorders. A systematic review and meta-analysis. Schizophrenia Research, 268, 193-204. doi: 10.1016/j.schres.2024.02.035

Response rates to sequential trials of antipsychotic medications according to algorithms or treatment guidelines in psychotic disorders. A systematic review and meta-analysis

2024

Journal Article

Prevalence of multimorbidity in people with and without severe mental illness: a systematic review and meta-analysis

Halstead, Sean, Cao, Chester, Høgnason Mohr, Grímur, Ebdrup, Bjørn H., Pillinger, Toby, McCutcheon, Robert A., Firth, Joseph, Siskind, Dan and Warren, Nicola (2024). Prevalence of multimorbidity in people with and without severe mental illness: a systematic review and meta-analysis. The Lancet Psychiatry, 11 (6), 431-442. doi: 10.1016/s2215-0366(24)00091-9

Prevalence of multimorbidity in people with and without severe mental illness: a systematic review and meta-analysis

2024

Journal Article

Overcoming clozapine’s adverse events: a narrative review of systematic reviews and meta-analyses

Tanzer, Timothy, Pham, Betty, Warren, Nicola, Barras, Michael, Kisely, Steve and Siskind, Dan (2024). Overcoming clozapine’s adverse events: a narrative review of systematic reviews and meta-analyses. Expert Opinion on Drug Safety, 23 (7), 811-831. doi: 10.1080/14740338.2024.2362796

Overcoming clozapine’s adverse events: a narrative review of systematic reviews and meta-analyses

2024

Journal Article

Sex differences between female and male individuals in antipsychotic efficacy and adverse effects in the treatment of schizophrenia

Galbally, Megan, Wynter, Karen, Siskind, Dan, Correll, Christoph U., Northwood, Korinne and Every-Palmer, Susanna (2024). Sex differences between female and male individuals in antipsychotic efficacy and adverse effects in the treatment of schizophrenia. CNS Drugs, 38 (7), 559-570. doi: 10.1007/s40263-024-01089-w

Sex differences between female and male individuals in antipsychotic efficacy and adverse effects in the treatment of schizophrenia

2024

Journal Article

Admissions for psychosis following agency-notified child maltreatment at 40-year-follow-up: results from the Childhood Adversity and Lifetime Morbidity (CALM) cohort

Kisely, Steve, Arnautovska, Urska, Siskind, Dan, Warren, Nicola and Najman, Jake Moses (2024). Admissions for psychosis following agency-notified child maltreatment at 40-year-follow-up: results from the Childhood Adversity and Lifetime Morbidity (CALM) cohort. Schizophrenia Research, 267, 247-253. doi: 10.1016/j.schres.2024.03.040

Admissions for psychosis following agency-notified child maltreatment at 40-year-follow-up: results from the Childhood Adversity and Lifetime Morbidity (CALM) cohort

2024

Conference Publication

Frailty And Severe Mental Illness In The UK Biobank

Warren, N., Leske, S., Arnautovska, U., Northwood, K., Kisely, S. and Siskind, D. (2024). Frailty And Severe Mental Illness In The UK Biobank. RANZCP 2024 Congress, Canberra, ACT Australia, 19-24 May 2023. London, United Kingdom: SAGE Publications.

Frailty And Severe Mental Illness In The UK Biobank

2024

Conference Publication

Evaluating The Epidemiology Of Clozapine-associated Neutropenia Among People On Clozapine Across Australia And Aotearoa New Zealand: A Retrospective Cohort Study

Northwood, K., Myles, N., Clark, S., Every-Palmer, S., Myles, H., Kisely, S., Warren, N. and Siskind, D. (2024). Evaluating The Epidemiology Of Clozapine-associated Neutropenia Among People On Clozapine Across Australia And Aotearoa New Zealand: A Retrospective Cohort Study. RANZCP 2024 Congress, Canberra, ACT Australia, 19-24 May 2023. London, United Kingdom: SAGE Publications.

Evaluating The Epidemiology Of Clozapine-associated Neutropenia Among People On Clozapine Across Australia And Aotearoa New Zealand: A Retrospective Cohort Study

2024

Conference Publication

Physical Activity Interventions Conducted Within Residential Mental Health Rehabilitation Settings For People With Severe Mental Illness

Korman, N., Parker, S., Siskind, D., Warren, N., Suetani, S. and Dark, F. (2024). Physical Activity Interventions Conducted Within Residential Mental Health Rehabilitation Settings For People With Severe Mental Illness. RANZCP 2024 Congress, Canberra, ACT Australia, 19-24 May 2023. London, United Kingdom: SAGE Publications.

Physical Activity Interventions Conducted Within Residential Mental Health Rehabilitation Settings For People With Severe Mental Illness

2024

Conference Publication

Multimorbidity And Severe Mental Illness

Halstead, S., Siskind, D., Cao, C. and Warren, N. (2024). Multimorbidity And Severe Mental Illness. RANZCP 2024 Congress, Canberra, ACT Australia, 19–23 May 2024. London, United Kingdom: SAGE Publications.

Multimorbidity And Severe Mental Illness

2024

Conference Publication

Considering The Whole Person: Physical Health Interventions For People With Severe Mental Illness

Warren, N., Halstead, S., Korman, N. and Siskind, D. (2024). Considering The Whole Person: Physical Health Interventions For People With Severe Mental Illness. RANZCP 2024 Congress, Canberra, ACT Australia, 19-24 May 2023. London, United Kingdom: SAGE Publications.

Considering The Whole Person: Physical Health Interventions For People With Severe Mental Illness

2024

Conference Publication

Hope Frailty Intervention: Utility Of Comprehensive Geriatric Assessment In Younger Outpatients With Severe Mental Illness

Siskind, D., Arnautovska, U., Soole, R., Kwan, W., Reid, N., Baker, A., Gordon, E., Hubbard, R. and Warren, N. (2024). Hope Frailty Intervention: Utility Of Comprehensive Geriatric Assessment In Younger Outpatients With Severe Mental Illness. RANZCP 2024 Congress, Canberra, ACT Australia, 19–23 May 2024. London, United Kingdom: SAGE Publications.

Hope Frailty Intervention: Utility Of Comprehensive Geriatric Assessment In Younger Outpatients With Severe Mental Illness

2024

Journal Article

Associations between child maltreatment and hospital admissions for alcohol and other substance use‐related disorders up to 40 years of age: results from the Childhood Adversity and Lifetime Morbidity study

Bull, Claudia, Trott, Mike, Najman, Jake Moses, Arnautovska, Urska, Siskind, Dan, Warren, Nicola and Kisely, Steve (2024). Associations between child maltreatment and hospital admissions for alcohol and other substance use‐related disorders up to 40 years of age: results from the Childhood Adversity and Lifetime Morbidity study. Addiction, 119 (7), 1-11. doi: 10.1111/add.16479

Associations between child maltreatment and hospital admissions for alcohol and other substance use‐related disorders up to 40 years of age: results from the Childhood Adversity and Lifetime Morbidity study

2024

Journal Article

Inflammatory cerebrospinal fluid markers in schizophrenia spectrum disorders: a systematic review and meta-analysis of 69 studies with 5710 participants

Warren, Nicola, O'Gorman, Cullen, Horgan, Isabelle, Weeratunga, Milleni, Halstead, Sean, Moussiopoulou, Joanna, Campana, Mattia, Yakimov, Vladislav, Wagner, Elias and Siskind, Dan (2024). Inflammatory cerebrospinal fluid markers in schizophrenia spectrum disorders: a systematic review and meta-analysis of 69 studies with 5710 participants. Schizophrenia Research, 266, 24-31. doi: 10.1016/j.schres.2024.02.001

Inflammatory cerebrospinal fluid markers in schizophrenia spectrum disorders: a systematic review and meta-analysis of 69 studies with 5710 participants

2024

Journal Article

Physical multimorbidity and mental illness: A global challenge

Halstead, Sean, Sartorius, Norman, Every-Palmer, Susanna, Siddiqi, Najma, de Girolamo, Giovanni, Siskind, Dan and Warren, Nicola (2024). Physical multimorbidity and mental illness: A global challenge. Australian and New Zealand Journal of Psychiatry, 58 (4), 293-296. doi: 10.1177/00048674241235587

Physical multimorbidity and mental illness: A global challenge

2024

Journal Article

Emergency department presentations for deliberate self-harm and suicidal ideation in 25–39 years olds following agency-notified child maltreatment: results from the Childhood Adversity and Lifetime Morbidity (CALM) study

Kisely, S., Bull, C., Trott, M., Arnautovska, U., Siskind, D., Warren, N. and Najman, J. Moses (2024). Emergency department presentations for deliberate self-harm and suicidal ideation in 25–39 years olds following agency-notified child maltreatment: results from the Childhood Adversity and Lifetime Morbidity (CALM) study. Epidemiology and Psychiatric Sciences, 33 e18, 1-7. doi: 10.1017/s2045796024000192

Emergency department presentations for deliberate self-harm and suicidal ideation in 25–39 years olds following agency-notified child maltreatment: results from the Childhood Adversity and Lifetime Morbidity (CALM) study

Current funding

  • 2024 - 2028
    A hybrid-II implementation-effectiveness trial of a peer-supported self-management tool for young people in preparation for early intervention in psychosis service discharge (MY PREP-ED) (Ex USYD)
    Medical Research Futures Fund
    Open grant
  • 2023 - 2028
    Self-care of Multimorbidity in schizophrenia supported by Peer workers: a Co-designed health Information Technology (SiMPlicITy) (externally led NHMRC 2022 Targeted Call administered via Uni of Syd)
    University of Sydney
    Open grant
  • 2023 - 2027
    Using risk profiles to overcome challenges in incorporating polygenic risk scores into clinical mental health practice (QIMR administered MRFF Genomics Health Future Mission grant)
    Queensland Institute of Medical Research
    Open grant
  • 2022 - 2029
    Schizophrenia and Weight Improvement From Tirzepatide (SWIFT)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2027
    Mental Health Australia General Clinical Trial Network (MAGNET) (MRFF Million Minds Mental Health Research Grant Led by Deakin University)
    Deakin University
    Open grant
  • 2021 - 2025
    Reducing the mortality gap for people with schizophrenia
    NHMRC Investigator Grants
    Open grant
  • 2020 - 2026
    Helping people with schizophrenia living longer, healthier lives
    Queensland Advancing Clinical Research Fellowship
    Open grant
  • 2019 - 2025
    What is the impact of the National Bowel Cancer Screening Program on colorectal cancer outcomes for people over the age of 50 with severe mental illness?
    Cancer Council Australia
    Open grant

Past funding

  • 2023 - 2024
    Cannabidiol (CBD) for Clozapine Refractory Schizophrenia (CanCloz)
    University of Sydney
    Open grant
  • 2022 - 2024
    A 40-year life course study of the effects of child maltreatment using linked birth cohort and administrative health data
    Metro South Health Research Support Scheme Project Grant
    Open grant
  • 2019 - 2021
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies
    NHMRC Project Grant
    Open grant
  • 2019 - 2022
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies (NHMRC Project Grant led by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2018 - 2020
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    Society for Mental Health Research Inc
    Open grant
  • 2018 - 2019
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    The Australian Diabetes Society
    Open grant
  • 2017 - 2018
    Avant Doctors in Training Research Scholarship Program 2017
    Avant Mutual Group Limited
    Open grant
  • 2017 - 2019
    A comparison study of three physical activity measurement tools examining acceptability in people with psychotic disorders
    Society for Mental Health Research Inc
    Open grant
  • 2017 - 2019
    Acceptability of physical activity measures in people with psychotic disorders
    Royal Australian & New Zealand College Psychiatrists
    Open grant
  • 2016 - 2019
    Cardiometabolic Health of People with Severe and Persistent Mental Illness
    NHMRC Early Career Fellowships
    Open grant
  • 2016 - 2019
    N-Acetyl Cysteine In Schizophrenia Resistant to Clozapine: A Double-Blind Randomised Placebo-Controlled Trial Targeting Negative Symptoms (NHMRC Project grant administed by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2015 - 2017
    Vaporising smoking-related harms in people with severe and persistent mental illness: A study of the acceptability of vaporised nicotine products for smoking cessation or long-term substitution
    Monash University
    Open grant
  • 2015 - 2017
    Quantifying the burden of perinatal depression in Australia and New Zealand
    RANZCP Pat, Toni and Peter Kinsman Research Scholarship
    Open grant
  • 2013 - 2016
    A MAP to better care: Applying the principles of advanced directives and motivational interviewing to discharge planning for psychiatric patients
    Australian Centre for Health Services Innovation
    Open grant

Availability

Professor Dan Siskind is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Professor Dan Siskind directly for media enquiries about:

  • Cardiometabolic co-morbidity of schizophrenia
  • Treatment Refractory Schizophrenia

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au